This inventor holds 4 USPTO granted patents. Top assignees: University of Arkansas, Other. Active years: 2001-2006.
Company Filing History:
3 out of 849 
1 out of 834,350 Years Active: 2001-2006
Title: Barry Hurlburt: Innovator in Viral and Bacterial Inhibition
Introduction
Barry Hurlburt is a notable inventor based in Little Rock, AR (US). He has made significant contributions to the fields of virology and bacteriology through his innovative patents. With a total of 4 patents, Hurlburt's work focuses on developing methods to combat viral and bacterial infections.
Latest Patents
Hurlburt's latest patents include groundbreaking inventions such as the "Mutated herpes simplex virus type 1 thymidine kinases and uses thereof." This invention provides new site-specific HSV-thymidine kinase mutants that exhibit improved nucleoside analog metabolizing activity due to low or no thymidine phosphorylation ability. Additionally, it offers a method for killing target cells using these mutants combined with a prodrug. Another significant patent is titled "Inhibitors of staphylococcus SarA protein function involved in the expression of staphylococcal virulence factors and the use thereof in treating staphylococcal infections." This invention relates to inhibitors that interfere with the binding of the SarA protein to its binding sites, which is crucial for the expression of staphylococcal virulence factors. The patent also outlines methods for designing, synthesizing, and identifying these inhibitors.
Career Highlights
Throughout his career, Barry Hurlburt has worked with esteemed institutions, including the University of Arkansas. His research has led to advancements in understanding and treating infections caused by herpes simplex virus and Staphylococcus bacteria.
Collaborations
Hurlburt has collaborated with notable colleagues such as Tammy M Rechtin and Richard Drake. Their combined expertise has contributed to the success of his innovative projects.
Conclusion
Barry Hurlburt's contributions to the fields of virology and bacteriology through his patents demonstrate his commitment to advancing medical science. His work continues to impact the treatment of viral and bacterial infections, showcasing the importance of innovation in healthcare.